Who are Chlorure de sodium 0.9%'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Plegisol In Plastic Container, saline serum, Plasma-lyte (dynamic group), Isotonic sodium chloride 0.9 percent, Standard Oral Rehydration, serum physiologic.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/chlorure-de-sodium-0-9.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Chlorure de sodium 0.9% — Competitive Intelligence Brief

Chlorure de sodium 0.9% (Chlorure de sodium 0.9%) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Electrolyte replacement solution. Area: Fluid and electrolyte management.

marketed Electrolyte replacement solution Fluid and electrolyte management Small molecule Live · refreshed every 30 min

Target snapshot

Chlorure de sodium 0.9% (Chlorure de sodium 0.9%) — Centre Hospitalier Universitaire Dijon. Sodium chloride 0.9% is an isotonic saline solution that replaces fluid and electrolytes in the body.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Chlorure de sodium 0.9% TARGET	Chlorure de sodium 0.9%	Centre Hospitalier Universitaire Dijon	marketed	Electrolyte replacement solution
Plegisol In Plastic Container	Calcium Chloride	Pfizer	marketed	Electrolyte replacement solution	Electrolyte balance and fluid homeostasis	1971-01-01
saline serum	saline serum	Hédi Chaker Hospital	marketed	Crystalloid fluid / Electrolyte replacement solution
Plasma-lyte (dynamic group)	Plasma-lyte (dynamic group)	Algemeen Ziekenhuis Maria Middelares	marketed	Crystalloid intravenous fluid / Electrolyte replacement solution
Isotonic sodium chloride 0.9 percent	Isotonic sodium chloride 0.9 percent	Rigshospitalet, Denmark	marketed	Crystalloid fluid / Electrolyte replacement solution
Standard Oral Rehydration	Standard Oral Rehydration	Federico II University	marketed	Electrolyte replacement solution
serum physiologic	serum physiologic	TC Erciyes University	marketed	Electrolyte replacement solution

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Electrolyte replacement solution class)

Baxter Healthcare Corporation · 1 drug in this class
Centre Hospitalier Universitaire Dijon · 1 drug in this class
Centre Hospitalier Universitaire de Nice · 1 drug in this class
Department of Medical Services Ministry of Public Health of Thailand · 1 drug in this class
Federico II University · 1 drug in this class
Hospital Universitari Vall d'Hebron Research Institute · 1 drug in this class
Nepal Health Research Council · 1 drug in this class
Pfizer · 1 drug in this class
Shanghai Hengrui Pharmaceutical Co., Ltd. · 1 drug in this class
TC Erciyes University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Chlorure de sodium 0.9% — Competitive Intelligence Brief. https://druglandscape.com/ci/chlorure-de-sodium-0-9. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab